Cargando…

Influence of metabolic syndrome superposition on familial combined hyperlipoproteinemia cardiovascular complication rate

INTRODUCTION: Familial combined hyperlipoproteinemia (FCHL) is a very common and aggressive genetic mixed hyperlipoproteinemia, with many features similar to that of the metabolic syndrome (MS). We aimed to evaluate whether the presence of the MS per se could account for a significant part of the el...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cicero, Arrigo F.G., Derosa, Giuseppe, Maffioli, Pamela, Reggi, Alessandra, Grandi, Elisa, Borghi, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2013
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648832/ https://www.ncbi.nlm.nih.gov/pubmed/23671433 http://dx.doi.org/10.5114/aoms.2013.34537

Ejemplares similares

Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular effects
por: Cicero, Arrigo F.G, et al.
Publicado: (2012)

Retargeting the management of hypercholesterolemia – focus on evolocumab
por: Colletti, Alessandro, et al.
Publicado: (2016)

Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data
por: Borghi, Claudio, et al.
Publicado: (2006)

Omega-3 polyunsaturated fatty acids: Their potential role in blood pressure prevention and management
por: BORGHI, CLAUDIO, et al.
Publicado: (2006)

Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)
por: Grützmacher, P., et al.
Publicado: (2017)

Therapeutic management of hyperlipoproteinemia (a)
por: Kosmas, Constantine E, et al.
Publicado: (2019)

Short-term effects of a combined nutraceutical of insulin-sensitivity, lipid level and indexes of liver steatosis: a double-blind, randomized, cross-over clinical trial
por: Cicero, Arrigo FG, et al.
Publicado: (2015)

Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study
por: Borghi, Claudio, et al.
Publicado: (2008)

Profile of evolocumab and its potential in the treatment of hyperlipidemia
por: Cicero, Arrigo FG, et al.
Publicado: (2015)

Lipid-lowering and anti-inflammatory effects of omega 3 ethyl esters and krill oil: a randomized, cross-over, clinical trial
por: Cicero, Arrigo F.G., et al.
Publicado: (2016)

Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study
por: Cicero, Arrigo F.G., et al.
Publicado: (2015)

Prevalent Seasoning and Cooking Fats, Arterial Stiffness and Blood Lipid Pattern in a Rural Population Sample: Data from the Brisighella Heart Study
por: Cicero, Arrigo F.G., et al.
Publicado: (2020)

Arterial Stiffness, Sugar-Sweetened Beverages and Fruits Intake in a Rural Population Sample: Data from the Brisighella Heart Study
por: Cicero, Arrigo F.G., et al.
Publicado: (2019)

Three arms, double-blind, non-inferiority, randomized clinical study testing the lipid-lowering effect of a novel dietary supplement containing red yeast rice and artichoke extracts compared to Armolipid Plus(®) and placebo
por: Cicero, Arrigo F.G., et al.
Publicado: (2023)

Misinterpreting data in lipidology in the era of COVID-19
por: Fogacci, Federica, et al.
Publicado: (2020)

A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO(®)) on LDL Cholesterol Levels and Lipid Pattern in Subjects with Sub-Optimal Blood Cholesterol Levels (NATCOL Study)
por: Cicero, Arrigo F.G., et al.
Publicado: (2020)

Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a)
por: Kosmas, Constantine E., et al.
Publicado: (2023)

Decoherence rate of mass superpositions
por: Stodolsky, L
Publicado: (1996)

Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications
por: Derosa, Giuseppe, et al.
Publicado: (2021)

Increased cardiovascular risk associated with hyperlipoproteinemia (a) and the challenges of current and future therapeutic possibilities
por: Fras, Zlatko
Publicado: (2020)

Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study
por: Cicero, Arrigo F. G., et al.
Publicado: (2022)

A Randomized Placebo-Controlled Clinical Trial to Evaluate the Medium-Term Effects of Oat Fibers on Human Health: The Beta-Glucan Effects on Lipid Profile, Glycemia and inTestinal Health (BELT) Study
por: Cicero, Arrigo F.G., et al.
Publicado: (2020)

Prevention of cardiovascular complications in patients with Lp(a)-hyperlipoproteinemia and progressive cardiovascular disease by long-term lipoprotein apheresis according to German national guidelines
por: Klingel, Reinhard, et al.
Publicado: (2017)

Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes
por: Derosa, Giuseppe, et al.
Publicado: (2011)

α-Glucosidase inhibitors and their use in clinical practice
por: Derosa, Giuseppe, et al.
Publicado: (2012)

A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus
por: Derosa, Giuseppe, et al.
Publicado: (2016)

A curious case of hypoglycaemia
por: Derosa, Giuseppe, et al.
Publicado: (2013)

Ertugliflozin: a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetes
por: Derosa, Giuseppe, et al.
Publicado: (2018)

Eruptive Xanthomas Caused by Primary Type V Hyperlipoproteinemia
por: Nakamura, Yoshihiro, et al.
Publicado: (2021)

Hyperlipoproteinemia(a) and Severe Coronary Artery Lesion Types
por: Ilina, Larisa N., et al.
Publicado: (2022)

Do the Lactotripeptides Isoleucine–Proline–Proline and Valine–Proline–Proline Reduce Systolic Blood Pressure in European Subjects? A Meta-Analysis of Randomized Controlled Trials
por: Cicero, Arrigo F.G., et al.
Publicado: (2013)

Effects of a Combination of Berberis aristata, Silybum marianum and Monacolin on Lipid Profile in Subjects at Low Cardiovascular Risk; A Double-Blind, Randomized, Placebo-Controlled Trial
por: Giuseppe, Derosa, et al.
Publicado: (2017)

A rare case of COVID-19 pneumonia with severe hyperlipoproteinemia
por: Shimoda, Masafumi, et al.
Publicado: (2022)

A Case of Type V Hyperlipoproteinemia Resistant to Insulin Treatment
por: Mangeshkar, Shaunak, et al.
Publicado: (2023)

Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study
por: Cicero, Arrigo Francesco Giuseppe, et al.
Publicado: (2018)

Short-Term Effect of a New Oral Sodium Hyaluronate Formulation on Knee Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
por: Cicero, Arrigo F. G., et al.
Publicado: (2020)

COVID-19-Related Quarantine Effect on Dietary Habits in a Northern Italian Rural Population: Data from the Brisighella Heart Study
por: Cicero, Arrigo F. G., et al.
Publicado: (2021)

Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology
por: Ertek, Sibel, et al.
Publicado: (2013)

Self-Reported Coffee Consumption and Central and Peripheral Blood Pressure in the Cohort of the Brisighella Heart Study
por: Cicero, Arrigo F. G., et al.
Publicado: (2023)

SUN-056 Recurrent Pancreatitis Induced by Uncontrolled Type V Hyperlipoproteinemia
por: Rivera Rivero, Bianshly, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m3v7m5l9nr6i764r1ii0p9bqit